PE20050897A1 - Nuevos antagonistas del receptor muscarinico m3 de acetilcolina - Google Patents
Nuevos antagonistas del receptor muscarinico m3 de acetilcolinaInfo
- Publication number
- PE20050897A1 PE20050897A1 PE2004001185A PE2004001185A PE20050897A1 PE 20050897 A1 PE20050897 A1 PE 20050897A1 PE 2004001185 A PE2004001185 A PE 2004001185A PE 2004001185 A PE2004001185 A PE 2004001185A PE 20050897 A1 PE20050897 A1 PE 20050897A1
- Authority
- PE
- Peru
- Prior art keywords
- carbonyl
- methyl
- furanil
- amino
- receptor
- Prior art date
Links
- UQOFGTXDASPNLL-XHNCKOQMSA-N Muscarine Chemical compound C[C@@H]1O[C@H](C[N+](C)(C)C)C[C@H]1O UQOFGTXDASPNLL-XHNCKOQMSA-N 0.000 title 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- -1 AMINO Chemical class 0.000 abstract 7
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical group [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 2
- JFSPBVWPKOEZCB-UHFFFAOYSA-N fenfuram Chemical compound O1C=CC(C(=O)NC=2C=CC=CC=2)=C1C JFSPBVWPKOEZCB-UHFFFAOYSA-N 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 206010006458 Bronchitis chronic Diseases 0.000 abstract 1
- 102000014415 Muscarinic acetylcholine receptor Human genes 0.000 abstract 1
- 108050003473 Muscarinic acetylcholine receptor Proteins 0.000 abstract 1
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical group C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 abstract 1
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 abstract 1
- FIULGFJIHJJXMT-UHFFFAOYSA-N [C]1[N]C=CC=C1 Chemical group [C]1[N]C=CC=C1 FIULGFJIHJJXMT-UHFFFAOYSA-N 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 206010006451 bronchitis Diseases 0.000 abstract 1
- 208000007451 chronic bronchitis Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 1
- VMVNZNXAVJHNDJ-UHFFFAOYSA-N methyl 2,2,2-trifluoroacetate Chemical compound COC(=O)C(F)(F)F VMVNZNXAVJHNDJ-UHFFFAOYSA-N 0.000 abstract 1
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical class [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 abstract 1
- 208000005069 pulmonary fibrosis Diseases 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
REFERIDA A UN COMPUESTO DE FORMULA I DONDE X ES C, O; Y ES C, N; n ES 1-3; m ES 1-3; p ES 0-2; W ES O, S, NH; U ES NR3, O, ENLACE; R3 ES H, ALQUILO C1-C8, CICLOALQUILO C3-C8, ENTRE OTROS; q ES 0-7; h ES 0-2; g 1-3; V ES FENILO, TIOFENILO, FURANILO, ENTRE OTROS; R4 ES H, OH, AMINO, ENTRE OTROS; k ES 0-5; T ES FENILO, PIRIDINILO, PIRROL, ENTRE OTROS; R5 ES OXAZOLILO, IMIDAZOLILO, OXADIAZOLILO, ENTRE OTROS; R1 ES H, FENILO, FURANIL, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: TRIFLUOROACETATO DE N-{(3S)-1-[(3-HIDROXIFENIL)METIL]-1-METIL-3-PIPERIDINOIL}-N-[({5-[(METILOXI)CARBONIL]-2-FURANIL}AMINO)CARBONIL]-L-TIROSINAMIDA, TRIFLUOROACETATO DE N-[({4-[(ETILOXI)CARBONIL]CICLOHEXIL}AMINO)CARBONIL]-N-{(3S)-1-[(3-HIDROXIFENIL)METIL]-1-METIL-3-PIPERIDINOIL}- L-TIROSINAMIDA, ENTRE OTROS. DICHOS COMPUESTOS SON UTILES EN TRATAMIENTO DE ENFERMEDADES MEDIADAS POR EL RECEPTOR MUSCARINICO TALES COMO FIBROSIS PULMONAR, ASMA, BRONQUITIS CRONICA, ENTRE OTRAS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52682403P | 2003-12-03 | 2003-12-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20050897A1 true PE20050897A1 (es) | 2005-11-06 |
Family
ID=34676665
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2004001185A PE20050897A1 (es) | 2003-12-03 | 2004-12-01 | Nuevos antagonistas del receptor muscarinico m3 de acetilcolina |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20070179184A1 (es) |
| EP (1) | EP1708702A2 (es) |
| JP (1) | JP2007513181A (es) |
| KR (1) | KR20060123415A (es) |
| AR (1) | AR046784A1 (es) |
| AU (1) | AU2004296207A1 (es) |
| BR (1) | BRPI0417215A (es) |
| CA (1) | CA2549272A1 (es) |
| IL (1) | IL175995A0 (es) |
| IS (1) | IS8515A (es) |
| MA (1) | MA28217A1 (es) |
| MX (1) | MXPA06006372A (es) |
| NO (1) | NO20062992L (es) |
| PE (1) | PE20050897A1 (es) |
| UY (1) | UY28645A1 (es) |
| WO (1) | WO2005055940A2 (es) |
| ZA (1) | ZA200604395B (es) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20050250A1 (es) * | 2003-07-17 | 2005-04-08 | Glaxo Group Ltd | Antagonistas de los receptores muscarinicos de la acetilcolina |
| US7507747B2 (en) * | 2003-10-17 | 2009-03-24 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
| PE20050489A1 (es) * | 2003-11-04 | 2005-09-02 | Glaxo Group Ltd | Antagonistas de receptores de acetilcolina muscarinicos |
| WO2005087236A1 (en) * | 2004-03-11 | 2005-09-22 | Glaxo Group Limited | Novel m3 muscarinic acetylcholine receptor antagonists |
| JP2007529511A (ja) * | 2004-03-17 | 2007-10-25 | グラクソ グループ リミテッド | Ｍ３ムスカリン性アセチルコリン受容体アンタゴニスト |
| US7384946B2 (en) * | 2004-03-17 | 2008-06-10 | Glaxo Group Limited | M3 muscarinic acetylcholine receptor antagonists |
| AR050902A1 (es) | 2004-04-27 | 2006-12-06 | Glaxo Group Ltd | Compuesto de quinuclidina, composicion farmaceutica que lo comprende y su usopara preparar dicha composicion |
| JP2007537261A (ja) * | 2004-05-13 | 2007-12-20 | グラクソ グループ リミテッド | ムスカリン性アセチルコリン受容体アンタゴニスト |
| US7781478B2 (en) | 2004-07-14 | 2010-08-24 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| US7868037B2 (en) | 2004-07-14 | 2011-01-11 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| US7772271B2 (en) | 2004-07-14 | 2010-08-10 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| BRPI0511834A (pt) | 2004-07-14 | 2008-01-08 | Ptc Therapeutics Inc | métodos por tratar hepatite c |
| WO2006019832A1 (en) | 2004-07-22 | 2006-02-23 | Ptc Therapeutics, Inc. | Thienopyridines for treating hepatitis c |
| MX2007001540A (es) * | 2004-08-10 | 2007-04-23 | Incyte Corp | Compuestos amido y sus usos como farmaceuticos. |
| WO2006055553A2 (en) * | 2004-11-15 | 2006-05-26 | Glaxo Group Limited | Novel m3 muscarinic acetylcholine receptor antagonists |
| US20080275079A1 (en) * | 2005-08-02 | 2008-11-06 | Glaxo Group Limited | M3 Muscarinic Acetylcholine Receptor Antagonists |
| WO2007022351A2 (en) * | 2005-08-18 | 2007-02-22 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
| CL2009000250A1 (es) | 2008-02-06 | 2009-09-11 | Glaxo Group Ltd | Compuestos derivados de pirazolo[3,4-b]piridina carboxamida; composicion farmaceutica que los comprende; y su uso en el tratamiento del asma, epoc y rinitis. |
| TW200946525A (en) | 2008-02-06 | 2009-11-16 | Glaxo Group Ltd | Dual pharmacophores-PDE4-muscarinic antagonistics |
| CL2009000248A1 (es) | 2008-02-06 | 2009-09-11 | Glaxo Group Ltd | Compuestos derivados de pirazolo [3,4-b] piridin-5-il, inhibidores de la fosfodiesterasa de tipo iv (pde4) y antagonista de receptores muscarinicos de acetilcolina (machr); composicion farmaceutica que los comprende; y su uso en la preparacion de medicamentos utiles en el tratamiento de enferemedades respiratorias y alergicas |
| WO2010094643A1 (en) | 2009-02-17 | 2010-08-26 | Glaxo Group Limited | Quinoline derivatives and their uses for rhinitis and urticaria |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5232978A (en) * | 1988-12-23 | 1993-08-03 | Merck Patent Gesellschaft Mit Beschrankter Haftung | 1-(2-arylethyl)-pyrrolidines |
| WO1999067221A1 (en) * | 1998-06-22 | 1999-12-29 | Elan Pharmaceuticals, Inc. | Compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
| US6420364B1 (en) * | 1999-09-13 | 2002-07-16 | Boehringer Ingelheim Pharmaceuticals, Inc. | Compound useful as reversible inhibitors of cysteine proteases |
-
2004
- 2004-12-01 UY UY28645A patent/UY28645A1/es unknown
- 2004-12-01 PE PE2004001185A patent/PE20050897A1/es not_active Application Discontinuation
- 2004-12-01 AR ARP040104479A patent/AR046784A1/es unknown
- 2004-12-03 US US10/581,230 patent/US20070179184A1/en not_active Abandoned
- 2004-12-03 BR BRPI0417215-9A patent/BRPI0417215A/pt not_active Application Discontinuation
- 2004-12-03 WO PCT/US2004/040667 patent/WO2005055940A2/en active Application Filing
- 2004-12-03 EP EP04813055A patent/EP1708702A2/en not_active Withdrawn
- 2004-12-03 JP JP2006542825A patent/JP2007513181A/ja active Pending
- 2004-12-03 KR KR1020067013265A patent/KR20060123415A/ko not_active Application Discontinuation
- 2004-12-03 CA CA002549272A patent/CA2549272A1/en not_active Abandoned
- 2004-12-03 MX MXPA06006372A patent/MXPA06006372A/es unknown
- 2004-12-03 AU AU2004296207A patent/AU2004296207A1/en not_active Abandoned
-
2006
- 2006-05-29 IL IL175995A patent/IL175995A0/en unknown
- 2006-05-30 ZA ZA200604395A patent/ZA200604395B/en unknown
- 2006-06-02 MA MA29068A patent/MA28217A1/fr unknown
- 2006-06-19 IS IS8515A patent/IS8515A/xx unknown
- 2006-06-27 NO NO20062992A patent/NO20062992L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL175995A0 (en) | 2006-10-05 |
| WO2005055940A2 (en) | 2005-06-23 |
| WO2005055940A3 (en) | 2005-09-15 |
| MXPA06006372A (es) | 2006-08-23 |
| IS8515A (is) | 2006-06-19 |
| EP1708702A2 (en) | 2006-10-11 |
| AR046784A1 (es) | 2005-12-21 |
| CA2549272A1 (en) | 2005-06-23 |
| JP2007513181A (ja) | 2007-05-24 |
| AU2004296207A1 (en) | 2005-06-23 |
| KR20060123415A (ko) | 2006-12-01 |
| BRPI0417215A (pt) | 2007-02-21 |
| ZA200604395B (en) | 2007-10-31 |
| UY28645A1 (es) | 2005-06-30 |
| NO20062992L (no) | 2006-06-27 |
| MA28217A1 (fr) | 2006-10-02 |
| US20070179184A1 (en) | 2007-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20050897A1 (es) | Nuevos antagonistas del receptor muscarinico m3 de acetilcolina | |
| ES2287782T3 (es) | Derivados de n-(heteroaril(piperidin-2-il)metil)benzamida, su preparacion y su aplicacion en terapeutica. | |
| JP6349360B2 (ja) | Ｃｂ２アゴニストとして有用なピリジン−２−アミド | |
| JP4563800B2 (ja) | ヒスタミンｈ３アンタゴニストとしての１−（４−ピペリジニル）ベンズイミダゾロン | |
| ES2272703T3 (es) | Derivados de piperidina acilados como agonistas de receptor de melanocortina-4. | |
| US20030109564A1 (en) | Novel non-imidazole compounds | |
| ES2283550T3 (es) | Derivados de piperidina acilados como antagonistas del receptor de. | |
| ES2336470T3 (es) | Piperidinas sustituidas como inhibidores de renina. | |
| US7368470B2 (en) | Substituted 3-pyrrolidine-indole derivatives | |
| JP5075818B2 (ja) | ５ｈｔ４受容体アゴニストとしてのインダゾールカルボキサミド誘導体 | |
| KR20080086921A (ko) | 레닌 억제제로서의 ３,５-치환된 피페리딘 화합물 | |
| PE20060076A1 (es) | Antagonistas del receptor de acetilcolina muscarinico | |
| US20080113959A1 (en) | {Beta}-Lactamyl vasopression V1a antagonists and methods of use | |
| PE20121354A1 (es) | Inhibidores del virus de la hepatitis c | |
| JP2013516415A5 (es) | ||
| AU2013265256A1 (en) | Substituted pyrrolidines as factor XIa inhibitors for the treatment of thromboembolic diseases | |
| CA2644368A1 (en) | Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient | |
| PE20081385A1 (es) | Derivados de nicotinamida | |
| ZA200306037B (en) | Derivatives of N-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same. | |
| SK16152002A3 (sk) | Farmacueticky účinné piperidínové deriváty, najmä ako modulátory aktivity chemokínového receptora | |
| MXPA05010816A (es) | Derivados de 4-(4- (heterociclilalcox}fenil)- 1-(heterociclil- carbonil) piperidina y compuestos relacionados como antagonistas de h3 de la histamina para el tratamiento de enfermedades neurologicas tales como alzheimer. | |
| PE20091431A1 (es) | Compuestos derivados de azetidinas, su preparacion y su aplicacion en terapeutica | |
| AU781837B2 (en) | 3-azabicyclo (3.1.0) hexane derivatives having opioid receptor affinity | |
| JP2007535548A5 (es) | ||
| PE20091579A1 (es) | Derivados de sulfonamida sustituida |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |